Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 10/20 | 0.34 |
| ▸ | CDC7 | O00311 | 6/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.34 |
| ▸ | CDK2 | P24941 | 6/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 6/20 | 0.34 |
| ▸ | DBF4 | Q9UBU7 | 6/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.33 |
| ▸ | CCNC | P24863 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.32 |
| ▸ | CLK1 | P49759 | 1/20 | 0.32 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.32 |
| ▸ | CDK3 | Q00526 | 1/20 | 0.32 |
| ▸ | DMPK | Q09013 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.32 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12404403 | 0.86 | SCN10A (0.56) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL15045647 | 0.84 | SCN10A (0.54) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL13242539 | 0.83 | SCN10A (0.43) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL10182844 | 0.81 | SCN10A (0.47) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL15045511 | 0.80 | SCN10A (0.47) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL13561572 | 0.79 | SCN10A (0.44) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL10201776 | 0.77 | SCN10A (0.53) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL12107546 | 0.76 | SCN10A (0.42) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL15844575 | 0.76 | SCN10A (0.58) | SCN10APARP1CDC7CCNE1CDK2 | |
| SCHEMBL15844574 | 0.76 | SCN10A (0.58) | SCN10APARP1CDC7CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796705-B2 | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases | MERCK SHARP & DOHME CORP. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2017-01-12 | — | — | US | disclosed |
| US-20130156731-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS | SCHERING CORPORATION | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156731-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS | HAVCR2, ELOC, ZC3HAV1 | SCN10A 3547/4885PARP1 2530/4885CDC7 3026/4885 |
| US-20170008879-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | ZC3HAV1, HAVCR2, ZC3HAV1L | SCN10A 4438/4885PARP1 1673/4885CDC7 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.